Indian price regulator stirs debate on essential drugs
This article was originally published in Scrip
Executive Summary
Despite attempting to make some seemingly well-intended efforts towards inclusive decision-making, India's National Pharmaceutical Pricing Authority (NPPA) may have stoked yet another debate with its latest notice on essential medicines.